Concepedia

Syed Rizvi

SR

36

Publications

4.4K

Citations

21

H-Index

2001

Active since

Affiliations

Gwynedd Mercy University(Current)

The University of Texas MD Anderson Cancer Center

Hackensack University Medical Center

Dana-Farber Cancer Institute

Levine Cancer Institute

Syed Rizvi is an author at Gwynedd Mercy University specializing in medicine, oncology, and immunology.

ORCID

Top concepts

Publications per year

2001–2024

36

Publications

36

Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study

Jesús G. Berdeja, Deepu Madduri, Saad Z. Usmani et al. · The Lancet · 2021 · 1.5K citations

, , +11

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 896 citations

, , +9

Everolimus for Previously Treated Advanced Gastric Cancer: Results of the Randomized, Double-Blind, Phase III GRANITE-1 Study

Atsushi Ohtsu, Jaffer A. Ajani, Yu-Xian Bai et al. · Journal of Clinical Oncology · 2013 · 487 citations · Full text

Phase I trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) in patients with advanced multiple myeloma

Paul G. Richardson, Constantine Mitsiades, Kathleen Colson et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2008 · 191 citations

Unemployment in multiple sclerosis: the contribution of personality and disease

Lauren B. Strober, Christopher Christodoulou, Ralph H. B. Benedict et al. · Multiple Sclerosis Journal · 2011 · 166 citations

Rows per page

1–5 of 36